Xerox (XRX) Q4 2025 earnings review
Acquisitions Mask Deep Organic Decay
Xerox reported headline revenue growth of 25.7% in Q4, driven entirely by the inorganic contributions of the Lexmark and ITsavvy acquisitions. Beneath the surface, the core business is deteriorating rapidly: Pro Forma revenue (adjusting for acquisitions) fell 9.0%, with weakness across both Print (-9.0%) and IT Solutions (-8.1%). Profitability also suffered, with Adjusted EPS swinging to a loss of $(0.10) and Adjusted Operating Margin compressing 140bps to 5.0%. While management guides for revenue above $7.5B in 2026, the current trajectory suggests this relies heavily on M&A integration rather than organic demand recovery.
🐂 Bull Case
Management reaffirmed the $300M Lexmark synergy target is 'ahead of plan.' If executed perfectly, cost-cutting could artificially prop up margins in 2026 despite revenue headwinds.
Despite a revenue drop, management claims IT Solutions pro forma bookings grew double digits in 2025 and the pipeline is larger than the prior year, suggesting potential stabilization in 2026.
🐻 Bear Case
Pro forma revenue fell 9.0% in Q4, accelerating from the full-year pro forma decline of 7.6%. This indicates the core business deterioration is worsening, not stabilizing.
The IT Solutions segment, touted as the future growth engine, shrank 8.1% on a pro forma basis in Q4. The narrative of 'double-digit bookings growth' is not converting to recognized revenue.
⚖️ Verdict: 🔴
Bearish. The acquisitions are effectively purchasing revenue to mask a shrinking core business. With pro forma revenues down nearly double-digits and margins compressing despite 'synergies,' the execution risk for 2026 is excessively high.
Key Themes
Pro Forma IT Solutions Decline
Reversing. IT Solutions is meant to be the diversification growth engine. However, despite the ITsavvy acquisition, the segment's pro forma revenue dropped 8.1% YoY in Q4. This contradicts the narrative of a successful pivot away from print. While management cites 'backlog fluctuations,' a revenue contraction in the growth segment is a major red flag.
Margin Compression Continues
Decelerating. Adjusted Operating Margin fell to 5.0% in Q4 (down 140bps YoY). Gross margin contracted 250bps to 28.6%. Management blamed product cost increases (memory costs) and tariffs. Even on a pro forma basis, margins are lower than the prior year, indicating that scale from acquisitions has not yet yielded operating leverage.
Macro and Tariff Headwinds
Management explicitly cited 'government uncertainty' and 'rising memory costs' as headwinds. Specifically, rising DRAM prices are impacting IT Solutions profitability. Tariff costs are also mounting, with limited ability to pass these through to customers in a shrinking demand environment.
Lexmark Integration & Synergies
Stable. The integration is 'ahead of plan,' with reaffirmed targets of at least $300M in synergies. This is the primary lever for the guided 2026 operating income expansion ($450-500M vs $248M in 2025). The success of the stock depends almost entirely on stripping costs out of the combined entity faster than revenue declines.
Debt Deleveraging Focus
Xerox paid down $366M of debt since the Lexmark close (July 1, 2025). This is critical as the company remains highly leveraged. 2026 Free Cash Flow guidance of ~$250M suggests deleveraging will continue, but at a modest pace relative to the debt load.
Other KPIs
Reversing. Swung to a loss from a profit of $0.36 in the prior year. This missed the positive expectations implied by the 'integration momentum' narrative.
Decelerating. Down $150M year-over-year. While positive, the decline limits capital allocation flexibility for buybacks or faster debt reduction.
Decelerating. While reported revenue is up 24.9% due to Lexmark, pro forma revenue dropped 9.0%. Equipment sales specifically fell 10.4% pro forma, signaling a continued freeze in customer capex.
Guidance
Accelerating vs FY25 ($7.02B). Implies ~7% growth reported, driven by a full year of Lexmark/ITsavvy contribution. However, considering the pro forma run rate, this guidance implies a significant stabilization of organic trends that has not yet been demonstrated.
Accelerating. Implies a near doubling from FY25 ($248M). This relies heavily on the $300M+ synergy target. If revenue misses, this profit target is at significant risk due to operating leverage.
Accelerating vs FY25 ($133M), but notably lower than historical levels (FY24 was $467M). Reflects higher interest expenses and cash costs to achieve synergies.
Key Questions
IT Solutions Disconnect
You cited double-digit pro forma bookings growth for IT Solutions in 2025, yet the segment's revenue declined 8.1% pro forma in Q4. Can you bridge this gap? Is this purely backlog timing, or are cancellations rising?
Organic Revenue Floor
Pro forma revenue accelerated to the downside in Q4 (-9.0% vs -7.6% for the full year). What specific macro or product drivers give you confidence that this trend will reverse to support the $7.5B+ guidance for 2026?
Margin Pressure vs. Synergies
Adjusted operating margin compressed to 5.0% in Q4 despite integration progress. With rising memory costs and tariffs cited as headwinds, how much of the $300M synergy target for 2026 is merely offsetting inflation versus driving net margin expansion?
Guidance Risk
Your 2026 Free Cash Flow guidance includes ~$335 million of forward flow benefits. What is the risk to this number if the underlying credit quality of the finance receivables portfolio deteriorates in this macro environment?